Depression spectrum disorder and differential effects of newer antidepressants on road safety. [Depressions-Spektrums-Störung und differenzielle Effekte neuerer Antidepressiva auf die Verkehrssicherheit].

Trial Profile

Depression spectrum disorder and differential effects of newer antidepressants on road safety. [Depressions-Spektrums-Störung und differenzielle Effekte neuerer Antidepressiva auf die Verkehrssicherheit].

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2012

At a glance

  • Drugs Agomelatine (Primary) ; Bupropion (Primary) ; Escitalopram (Primary) ; Mirtazapine (Primary) ; Reboxetine (Primary)
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top